Clinical Trials Browser

Prostatic Neoplasms × Hydroxychloroquine × 1 year × Clear all

NCT04011410 2025-04-11

Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer

Phase 2 Completed

20 enrolled 8 charts

Prostatic Neoplasms